VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ADCT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ADCTADC Therapeutics S.A.
$1.03$131M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksADCTQuarterly Financials

ADC Therapeutics S.A. (ADCT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ADC Therapeutics S.A. (ADCT) quarterly income statement — complete revenue, gross profit & net income history

ADCT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue20.85M23.06M16.43M18.84M23.03M16.91M18.46M17.41M18.05M16.79M14.49M19.28M18.99M69.8M76.32M17.29M46.5M17.01M13.15M3.76M
Revenue Growth %-9.47%36.36%-11.03%8.21%27.59%0.71%27.4%-9.71%-4.94%-75.94%-81.01%11.52%-59.16%310.34%480.52%359.87%----
Cost of Goods Sold3.62M1.7M1.2M836K2.06M1.37M851K1.22M2.51M125.14M366K1.13M-27K489K1.29M2.27M529K770K502K121K
COGS % of Revenue17.34%7.37%7.32%4.44%8.95%8.11%4.61%6.99%13.9%745.35%2.53%5.87%-0.14%0.7%1.7%13.11%1.14%4.53%3.82%3.22%
Gross Profit17.24M21.36M15.22M18M20.97M15.54M17.61M16.19M15.54M-108.36M14.13M18.15M19.02M69.31M75.03M15.03M45.97M16.24M12.64M3.64M
Gross Margin %82.66%92.63%92.68%95.56%91.05%91.89%95.39%93.01%86.1%-645.35%97.47%94.13%100.14%99.3%98.3%86.89%98.86%95.47%96.18%96.78%
Gross Profit Growth %-17.81%37.45%-13.56%11.18%34.93%114.34%24.68%-10.79%-18.28%-256.34%-81.17%20.81%-58.63%326.78%493.33%312.89%----
Operating Expenses42.48M39.48M46.19M62.15M49.44M47.98M53.18M45.23M49.16M-68.38M51.53M57.8M69.23M80.05M78.14M84.44M86.33M79.02M70.44M74.12M
OpEx % of Revenue203.74%171.23%281.21%329.9%214.63%283.71%288%259.82%272.29%-407.25%355.56%299.75%364.52%114.68%102.38%488.32%185.67%464.56%535.76%1971.3%
Selling, General & Admin22.6M21.44M19.01M18.97M-598K20.87M20.68M20.94M23.42M25.22M23.09M26.46M30.85M31.31M36.46M30.02M37.38M36.53M33.63M34.59M
SG&A % of Revenue108.41%92.99%115.75%100.69%-2.6%123.44%111.97%120.27%129.73%150.22%159.33%137.21%162.46%44.86%47.78%173.61%80.39%214.75%255.81%919.89%
Research & Development19.88M18.18M26.8M30.09M28.93M27.1M32.5M24.3M25.73M30.33M28.44M31.34M38.38M48.73M41.68M48.54M48.95M42.49M36.8M39.53M
R&D % of Revenue95.33%78.86%163.16%159.72%125.59%160.27%176.03%139.55%142.55%180.64%196.23%162.54%202.06%69.82%54.61%280.71%105.28%249.81%279.95%1051.41%
Other Operating Expenses0-144K377K1000K1000K0000-1000K000001000K0000
Operating Income-25.25M-18.12M-30.97M-44.15M-28.46M-32.44M-35.56M-29.04M-33.61M-39.98M-37.4M-39.65M-50.21M-10.74M-3.11M-69.41M-40.36M-62.78M-57.79M-70.48M
Operating Margin %-121.07%-78.6%-188.53%-234.34%-123.58%-191.82%-192.61%-166.81%-186.19%-238.11%-258.08%-205.62%-264.37%-15.38%-4.08%-401.43%-86.81%-369.08%-439.58%-1874.52%
Operating Income Growth %11.31%44.13%12.92%-52.02%15.32%18.87%4.92%26.75%33.06%-272.3%-1101.16%42.88%-24.39%82.9%94.61%1.52%42.88%19.51%-10.23%-56.8%
EBITDA-25.13M-18.01M-30.85M-43.31M-27.66M-31.64M-34.76M-28.2M-32.77M-39.64M-36.61M-38.84M-49.49M-10.16M-2.54M-68.83M-39.77M-62.02M-57.13M-69.85M
EBITDA Margin %-120.53%-78.11%-187.78%-229.88%-120.1%-187.13%-188.27%-161.99%-181.52%-236.11%-252.61%-201.41%-260.57%-14.56%-3.33%-398.04%-85.53%-364.62%-434.58%-1857.63%
EBITDA Growth %9.15%43.08%11.26%-53.55%15.58%20.18%5.05%27.38%33.78%-290.11%-1340.24%43.57%-24.43%83.62%95.55%1.46%43.26%19.64%-10%-56.92%
D&A (Non-Cash Add-back)113K113K122K840K801K793K802K838K843K335K793K812K723K576K572K586K594K759K658K635K
EBIT-25.25M6.2M-27.57M-42.4M-26.49M-19.63M-30.5M-23.03M-33.26M-39.98M-33.79M-42.34M-47.2M-12.64M-39.96M-56.52M-8.61M-46.83M-64.93M-69.77M
Net Interest Income-10.36M-10.66M-10.92M-11.06M-10.18M-9.29M-9.68M-9.43M-9.55M-4.38M-9.8M-7.94M-8.12M-8.18M-11.08M-8.79M9.09M-9.5M-4.25M-2.54M
Interest Income1.99M2.35M2.47M1.93M2.05M2.63M3.44M3.25M2.95M3.29M3.14M2.37M2.17M1.63M273K16K18.31M20K16K15K
Interest Expense12.35M13.01M13.39M13M12.23M11.92M13.12M12.68M12.5M7.67M12.94M10.31M10.29M9.8M11.36M8.8M9.22M9.52M4.26M2.56M
Other Income/Expense-7.72M11.31M-10M-11.24M-9.97M1.39M-8.31M-7.27M-12.83M-1.88M-10.49M-13.77M-8.65M-9.45M-48.2M4.09M22.53M6.43M-13.61M-1.85M
Pretax Income-32.97M-6.81M-40.97M-55.39M-38.44M-31.05M-43.88M-36.31M-46.44M-41.86M-47.89M-53.42M-58.86M-20.19M-51.32M-65.32M-17.83M-56.35M-71.4M-72.33M
Pretax Margin %-158.11%-29.55%-249.38%-294.03%-166.88%-183.61%-237.65%-208.56%-257.26%-249.32%-330.46%-277.03%-309.9%-28.93%-67.24%-377.77%-38.35%-331.29%-543.12%-1923.64%
Income Tax0-404K01.25M165K-321K90K234K163K43.17M-86K-4.5M518K3.97M-711K-947K-1.17M-21.97M145K240K
Effective Tax Rate %0%5.93%0%-2.26%-0.43%1.03%-0.21%-0.64%-0.35%-103.13%0.18%8.42%-0.88%-19.65%1.39%1.45%6.56%38.99%-0.2%-0.33%
Net Income-32.97M-6.41M-40.97M-56.65M-38.6M-30.73M-43.97M-36.54M-46.61M-85.03M-47.81M-48.92M-59.37M-24.16M-50.61M-64.37M-16.66M-34.38M-71.55M-72.57M
Net Margin %-158.11%-27.8%-249.38%-300.68%-167.59%-181.71%-238.13%-209.9%-258.16%-506.44%-329.86%-253.71%-312.63%-34.61%-66.31%-372.3%-35.83%-202.12%-544.22%-1930.03%
Net Income Growth %14.6%79.14%6.83%-55.01%17.17%63.86%8.03%25.3%21.5%-251.99%5.53%24%-256.37%29.74%29.27%11.29%67.67%38.53%-251.97%42.66%
Net Income (Continuing)-32.97M-6.41M-40.97M-56.65M-38.6M-30.73M-43.97M-36.54M-46.61M-85.03M-47.81M-48.92M-59.37M-24.16M-50.61M-64.37M-16.66M-34.38M-71.55M-72.57M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.21-0.04-0.30-0.50-0.36-0.29-0.42-0.38-0.56-1.03-0.58-0.58-0.73-0.30-0.65-0.84-0.22-0.45-0.93-0.95
EPS Growth %41.67%85.31%28.57%-31.58%35.71%71.84%27.59%34.48%23.29%-243.33%10.77%30.95%-231.82%33.33%30.11%11.58%67.16%38.36%-220.69%52.74%
EPS (Basic)-0.21-0.04-0.30-0.50-0.36-0.29-0.42-0.38-0.56-1.03-0.58-0.58-0.73-0.30-0.65-0.84-0.22-0.45-0.93-0.95
Diluted Shares Outstanding154.14M150.3M136.45M113.74M107.2M105.4M104.82M95.69M82.55M82.29M82.26M81.47M80.81M80.64M78.37M76.91M76.82M76.4M76.74M76.73M
Basic Shares Outstanding154.14M150.3M136.45M113.74M107.2M105.4M104.82M95.69M82.55M82.29M82.26M81.47M80.81M80.64M78.37M76.91M76.82M76.4M76.74M76.73M
Dividend Payout Ratio--------------------